Literature DB >> 12386071

Costs and gains of complex procedures to rehabilitate end stage ocular surface disease.

G Geerling1, C S C Liu, J R O Collin, J K G Dart.   

Abstract

BACKGROUND: The management of patients with end stage ocular surface disease sometimes requires extensive surgical treatment that can only be provided by specialised ophthalmology. The authors discuss the costs and gains of such complex techniques based on a case of bilateral corneal blindness secondary to Stevens-Johnson syndrome. METHODS AND
RESULTS: Despite multiple lid surgery for trichiasis and repeated corneal grafting for perforations a white female patient became bilaterally blind at the age of 29 years. She also suffered from disabling discomfort in the right dry eye. At the age of 52 a two stage osteo-odonto-keratoprosthesis achieved visual rehabilitation in the left eye and microvascular transplantation of an autologous, submandibular gland resulted in sufficient lubrication to alleviate her severe discomfort in the right eye. As a result of these procedures she was able to take up a regular job again. The total costs of rehabilitation were pound 13 661 which compare with annual gains and regains for society of pound 13 497. An additional pound 4625 was saved annually in guide dog costs.
CONCLUSION: This estimate shows that despite the expense of these complex techniques gains are made well within the second year after rehabilitation. In view of the benefit in quality of life for the patient and monetary savings for society these procedures should be funded by national health services at specialist centres.

Entities:  

Mesh:

Year:  2002        PMID: 12386071      PMCID: PMC1771375          DOI: 10.1136/bjo.86.11.1220

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  4 in total

1.  Cost-benefit analysis of diabetic eye disease.

Authors:  H Matz; M Falk; W Göttinger; G Kieselbach
Journal:  Ophthalmologica       Date:  1996       Impact factor: 3.250

2.  Transplantation of the autologous submandibular gland for most severe cases of keratoconjunctivitis sicca.

Authors:  G Geerling; P Sieg; G O Bastian; H Laqua
Journal:  Ophthalmology       Date:  1998-02       Impact factor: 12.079

3.  Gains from cataract surgery: visual function and quality of life.

Authors:  P Desai; A Reidy; D C Minassian; G Vafidis; J Bolger
Journal:  Br J Ophthalmol       Date:  1996-10       Impact factor: 4.638

4.  [Transplantation of autologous submandibular glands in very severe keratoconjunctivitis sicca. 2 year outcome].

Authors:  G Geerling; P Sieg; C Meyer; G O Bastian; H Laqua
Journal:  Ophthalmologe       Date:  1998-04       Impact factor: 1.059

  4 in total
  5 in total

1.  [Long-term follow-up after autologous submandibular gland transplantation in scarring keratoconjunctivitis with absolute dry eyes].

Authors:  C Schröder; S G Hakim; J R O Collin; P Sieg; G Geerling
Journal:  Ophthalmologe       Date:  2003-12       Impact factor: 1.059

2.  Cost effectiveness of the type II Boston keratoprosthesis.

Authors:  J D Ament; T P Stryjewski; S Pujari; S Siddique; G N Papaliodis; J Chodosh; C H Dohlman
Journal:  Eye (Lond)       Date:  2010-12-24       Impact factor: 3.775

Review 3.  [Mucous membrane pemphigoid with ocular involvement. Part II: therapy].

Authors:  T Meyer-ter-Vehn; E Schmidt; D Zillikens; G Geerling
Journal:  Ophthalmologe       Date:  2008-04       Impact factor: 1.059

4.  [Health-related quality of life after implantation of a keratoprosthesis with biological haptic].

Authors:  A Frings; S Schrader; K Hille; I Staab; G Geerling
Journal:  Ophthalmologe       Date:  2018-01       Impact factor: 1.059

Review 5.  An Evidence-Based Strategic Approach to Prevention and Treatment of Dry Eye Disease, a Modern Global Epidemic.

Authors:  Pragnya R Donthineni; Swapna S Shanbhag; Sayan Basu
Journal:  Healthcare (Basel)       Date:  2021-01-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.